Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionSRS Capital Advisors, Inc.
Latest Disclosed Ownership1,089 shares
Latest Disclosed Value $ 86,963
SRS Capital Advisors, Inc. reports 29.83% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 13, 2026 - SRS Capital Advisors, Inc. filed a 13F-HR form disclosing ownership of 1,089 shares of Edwards Lifesciences Corporation (MX:EW) valued at $86,963 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,552 shares of Edwards Lifesciences Corporation. This represents a change in shares of -29.83% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 1,089 -463 -29.83 87 -34.85 0.0025
2026-02-13 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 1,552 -48,893 -96.92 132 -96.64 0.0039
2025-11-14 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 50,445 49,342 4,473.44 3,923 4,357.95 0.0563
2025-08-12 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 1,103 -16 -1.43 88 8.64 0.0041
2025-05-15 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 1,119 -583 -34.25 81 -35.20 0.0052
2025-02-05 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 1,702 724 74.03 126 95.31 0.0079
2024-11-06 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 978 99 11.26 65 -20.99 0.0058
2024-08-06 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 879 244 38.43 81 35.00 0.0079
2024-05-14 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 635 10 1.60 61 27.66 0.0064
2024-02-06 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 625 -11 -1.73 48 6.82 0.0053
2023-11-14 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 636 474 292.59 44 193.33 0.0055
2023-08-14 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 162 7 4.52 15 25.00 0.0020
2023-05-16 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 155 -8 -4.91 13 0.00 0.0017
2023-02-24 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 163 -310 -65.54 12 -69.23 0.0017
2022-11-03 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 473 1 0.21 39 -13.33 0.0062
2022-08-22 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 472 24 5.36 45 -15.09 0.0068
2022-05-12 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 448 -27 -5.68 53 -14.52 0.0071
2022-02-08 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 475 0 0.00 62 14.81 0.0079
2021-11-05 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 475 -58 -10.88 54 -1.82 0.0074
2021-08-02 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 533 -7 -1.30 55 12.24 0.0075
2021-02-03 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 540 0 0.00 49 13.95 0.0073
2020-11-12 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 540 -160 -22.86 43 -10.42 0.0073
2020-08-06 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 700 -200 -22.22 48 -71.76 0.0085
2020-05-13 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 900 0 0.00 170 -19.05 0.0392
2020-02-07 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 900 0 0.00 210 6.06 0.0603
2019-11-01 2019-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 900 0 0.00 198 19.28 0.0597
2019-08-08 2019-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 900 -701 -43.79 166 -32.24 0.0553
2019-02-06 2018-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 1,601 933 139.67 245 111.21 0.0974
2018-11-05 2018-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 668 508 317.50 116 404.35 0.0467
2018-08-21 2018-06-30 13F EDWARDS LIFESCIENCES CORP COM COM 28176E108 160 46 40.35 23 53.33 0.0101
2018-05-14 2018-03-31 13F EDWARDS LIFESCIENCES CORP COM COM 28176E108 114 -25 -17.99 15 0.00 0.0078
2018-02-15 2017-12-31 13F EDWARDS LIFESCIENCES CORP COM COM 28176E108 139 0 0.00 15 0.00 0.0065
2017-11-15 2017-09-30 13F EDWARDS LIFESCIENCES CORP COM COM 28176E108 139 5 3.73 15 -6.25 0.0072
2017-08-14 2017-06-30 13F EDWARDS LIFESCIENCES CORP COM COM 28176E108 134 0 0.00 16 33.33 0.0077
2017-05-11 2017-03-31 13F EDWARDS LIFESCIENCES CORP COM COM 28176E108 134 0 0.00 12 -7.69 0.0058
2017-02-14 2016-12-31 13F EDWARDS LIFESCIENCES CORP COM COM 28176E108 134 134 13 0.0065
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.